[HTML][HTML] STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells

XH Liao, Y Xiang, CX Yu, JP Li, H Li, Q Nie, P Hu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
XH Liao, Y Xiang, CX Yu, JP Li, H Li, Q Nie, P Hu, J Zhou, TC Zhang
Oncotarget, 2017ncbi.nlm.nih.gov
Signal transducer and activator of transcription 3 (STAT3) controls cell survival, growth,
migration, and invasion. Here, we observed that STAT3 exerted anti-apoptotic effects in
breast cancer cells. On the other hand, miR-17-5p induced apoptosis in breast cancer cells,
and overexpression of miR-17-5p sensitized MCF-7 cells to paclitaxel-induced apoptosis via
STAT3. Overexpression of STAT3 in MCF-7 cells decreased paclitaxel-induced apoptosis,
but STAT3 knockout abolished the miR-17-5p-induced increases in apoptosis. Finally, miR …
Abstract
Signal transducer and activator of transcription 3 (STAT3) controls cell survival, growth, migration, and invasion. Here, we observed that STAT3 exerted anti-apoptotic effects in breast cancer cells. On the other hand, miR-17-5p induced apoptosis in breast cancer cells, and overexpression of miR-17-5p sensitized MCF-7 cells to paclitaxel-induced apoptosis via STAT3. Overexpression of STAT3 in MCF-7 cells decreased paclitaxel-induced apoptosis, but STAT3 knockout abolished the miR-17-5p-induced increases in apoptosis. Finally, miR-17-5p promoted apoptosis by increasing p53 expression, which was inhibited by STAT3. These results demonstrate a novel pathway via which miR-17-5p inhibits STAT3 and increases p53 expression to promote apoptosis in breast cancer cells.
ncbi.nlm.nih.gov